 mobihealthnews |
iSonea reaches milestone with launch of U.S. paediatric asthma study
Proactive Investors USA & Canada iSonea (ASX: ISN, OTCQX: ISOAY) has begun its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too young to be tested with … iSonea Announces Initiation of Pediatric Asthma Study iSonea begins recruiting for pediatric asthma trial iSonea to Build Mobile Asthma Management Apps on Qualcomm's Platform |
View full post on asthma – Google News